List of Tables
Table 1. Global Cancer Spit Test Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cancer Spit Test Device Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cancer Spit Test Device Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cancer Spit Test Device Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cancer Spit Test Device Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cancer Spit Test Device Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cancer Spit Test Device Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cancer Spit Test Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cancer Spit Test Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cancer Spit Test Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cancer Spit Test Device, Product Type & Application
Table 12. Global Key Manufacturers of Cancer Spit Test Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Spit Test Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Spit Test Device as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Spit Test Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cancer Spit Test Device Sales by Region (2020-2025) & (K Units)
Table 18. Global Cancer Spit Test Device Sales Market Share by Region (2020-2025)
Table 19. Global Cancer Spit Test Device Sales by Region (2026-2031) & (K Units)
Table 20. Global Cancer Spit Test Device Sales Market Share by Region (2026-2031)
Table 21. Global Cancer Spit Test Device Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cancer Spit Test Device Revenue Market Share by Region (2020-2025)
Table 23. Global Cancer Spit Test Device Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cancer Spit Test Device Revenue Market Share by Region (2026-2031)
Table 25. North America Cancer Spit Test Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cancer Spit Test Device Sales by Country (2020-2025) & (K Units)
Table 27. North America Cancer Spit Test Device Sales by Country (2026-2031) & (K Units)
Table 28. North America Cancer Spit Test Device Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cancer Spit Test Device Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cancer Spit Test Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cancer Spit Test Device Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cancer Spit Test Device Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cancer Spit Test Device Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cancer Spit Test Device Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cancer Spit Test Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cancer Spit Test Device Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cancer Spit Test Device Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cancer Spit Test Device Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cancer Spit Test Device Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Spit Test Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cancer Spit Test Device Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cancer Spit Test Device Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cancer Spit Test Device Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Spit Test Device Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cancer Spit Test Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cancer Spit Test Device Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cancer Spit Test Device Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cancer Spit Test Device Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cancer Spit Test Device Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cancer Spit Test Device Sales (K Units) by Type (2020-2025)
Table 51. Global Cancer Spit Test Device Sales (K Units) by Type (2026-2031)
Table 52. Global Cancer Spit Test Device Sales Market Share by Type (2020-2025)
Table 53. Global Cancer Spit Test Device Sales Market Share by Type (2026-2031)
Table 54. Global Cancer Spit Test Device Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cancer Spit Test Device Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cancer Spit Test Device Revenue Market Share by Type (2020-2025)
Table 57. Global Cancer Spit Test Device Revenue Market Share by Type (2026-2031)
Table 58. Global Cancer Spit Test Device Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cancer Spit Test Device Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cancer Spit Test Device Sales (K Units) by Application (2020-2025)
Table 61. Global Cancer Spit Test Device Sales (K Units) by Application (2026-2031)
Table 62. Global Cancer Spit Test Device Sales Market Share by Application (2020-2025)
Table 63. Global Cancer Spit Test Device Sales Market Share by Application (2026-2031)
Table 64. Global Cancer Spit Test Device Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cancer Spit Test Device Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cancer Spit Test Device Revenue Market Share by Application (2020-2025)
Table 67. Global Cancer Spit Test Device Revenue Market Share by Application (2026-2031)
Table 68. Global Cancer Spit Test Device Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cancer Spit Test Device Price (US$/Unit) by Application (2026-2031)
Table 70. Biocartis Group Company Information
Table 71. Biocartis Group Description and Business Overview
Table 72. Biocartis Group Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Biocartis Group Cancer Spit Test Device Product
Table 74. Biocartis Group Recent Developments/Updates
Table 75. BD Company Information
Table 76. BD Description and Business Overview
Table 77. BD Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BD Cancer Spit Test Device Product
Table 79. BD Recent Developments/Updates
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Laboratories Cancer Spit Test Device Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Roche Holding AG Company Information
Table 86. Roche Holding AG Description and Business Overview
Table 87. Roche Holding AG Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Roche Holding AG Cancer Spit Test Device Product
Table 89. Roche Holding AG Recent Developments/Updates
Table 90. Qiagen Company Information
Table 91. Qiagen Description and Business Overview
Table 92. Qiagen Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Qiagen Cancer Spit Test Device Product
Table 94. Qiagen Recent Developments/Updates
Table 95. Agilent Technologies Company Information
Table 96. Agilent Technologies Description and Business Overview
Table 97. Agilent Technologies Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Agilent Technologies Cancer Spit Test Device Product
Table 99. Agilent Technologies Recent Developments/Updates
Table 100. BioMerieux Company Information
Table 101. BioMerieux Description and Business Overview
Table 102. BioMerieux Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BioMerieux Cancer Spit Test Device Product
Table 104. BioMerieux Recent Developments/Updates
Table 105. Canvax Company Information
Table 106. Canvax Description and Business Overview
Table 107. Canvax Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Canvax Cancer Spit Test Device Product
Table 109. Canvax Recent Developments/Updates
Table 110. Color Health Inc Company Information
Table 111. Color Health Inc Description and Business Overview
Table 112. Color Health Inc Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Color Health Inc Cancer Spit Test Device Product
Table 114. Color Health Inc Recent Developments/Updates
Table 115. DNA Genotek Inc. Company Information
Table 116. DNA Genotek Inc. Description and Business Overview
Table 117. DNA Genotek Inc. Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. DNA Genotek Inc. Cancer Spit Test Device Product
Table 119. DNA Genotek Inc. Recent Developments/Updates
Table 120. Illumina Company Information
Table 121. Illumina Description and Business Overview
Table 122. Illumina Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Illumina Cancer Spit Test Device Product
Table 124. Illumina Recent Developments/Updates
Table 125. Miraclean Technology Co.,Ltd. Company Information
Table 126. Miraclean Technology Co.,Ltd. Description and Business Overview
Table 127. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product
Table 129. Miraclean Technology Co.,Ltd. Recent Developments/Updates
Table 130. Oasis Diagnostics Corporation Company Information
Table 131. Oasis Diagnostics Corporation Description and Business Overview
Table 132. Oasis Diagnostics Corporation Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Oasis Diagnostics Corporation Cancer Spit Test Device Product
Table 134. Oasis Diagnostics Corporation Recent Developments/Updates
Table 135. PeriRx Company Information
Table 136. PeriRx Description and Business Overview
Table 137. PeriRx Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. PeriRx Cancer Spit Test Device Product
Table 139. PeriRx Recent Developments/Updates
Table 140. Salimetrics Company Information
Table 141. Salimetrics Description and Business Overview
Table 142. Salimetrics Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Salimetrics Cancer Spit Test Device Product
Table 144. Salimetrics Recent Developments/Updates
Table 145. Sarstedt Company Information
Table 146. Sarstedt Description and Business Overview
Table 147. Sarstedt Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Sarstedt Cancer Spit Test Device Product
Table 149. Sarstedt Recent Developments/Updates
Table 150. Siemens Healthineers Company Information
Table 151. Siemens Healthineers Description and Business Overview
Table 152. Siemens Healthineers Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Siemens Healthineers Cancer Spit Test Device Product
Table 154. Siemens Healthineers Recent Developments/Updates
Table 155. Thermo Fisher Scientific Company Information
Table 156. Thermo Fisher Scientific Description and Business Overview
Table 157. Thermo Fisher Scientific Cancer Spit Test Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Thermo Fisher Scientific Cancer Spit Test Device Product
Table 159. Thermo Fisher Scientific Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Cancer Spit Test Device Distributors List
Table 163. Cancer Spit Test Device Customers List
Table 164. Cancer Spit Test Device Market Trends
Table 165. Cancer Spit Test Device Market Drivers
Table 166. Cancer Spit Test Device Market Challenges
Table 167. Cancer Spit Test Device Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cancer Spit Test Device
Figure 2. Global Cancer Spit Test Device Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Spit Test Device Market Share by Type: 2024 & 2031
Figure 4. Passive Drool Collection Methods Product Picture
Figure 5. Oral Swab Collection Methods Product Picture
Figure 6. Global Cancer Spit Test Device Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Spit Test Device Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Diagnostic Laboratories
Figure 10. Oncology Speciality Clinics
Figure 11. Cancer Research Institutes
Figure 12. Others
Figure 13. Global Cancer Spit Test Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Spit Test Device Market Size (2020-2031) & (US$ Million)
Figure 15. Global Cancer Spit Test Device Sales (2020-2031) & (K Units)
Figure 16. Global Cancer Spit Test Device Average Price (US$/Unit) & (2020-2031)
Figure 17. Cancer Spit Test Device Report Years Considered
Figure 18. Cancer Spit Test Device Sales Share by Manufacturers in 2024
Figure 19. Global Cancer Spit Test Device Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Cancer Spit Test Device Players: Market Share by Revenue in Cancer Spit Test Device in 2024
Figure 21. Cancer Spit Test Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Cancer Spit Test Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Cancer Spit Test Device Sales Market Share by Country (2020-2031)
Figure 24. North America Cancer Spit Test Device Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Spit Test Device Sales Market Share by Country (2020-2031)
Figure 28. Europe Cancer Spit Test Device Revenue Market Share by Country (2020-2031)
Figure 29. Germany Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Cancer Spit Test Device Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Cancer Spit Test Device Revenue Market Share by Region (2020-2031)
Figure 36. China Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Cancer Spit Test Device Sales Market Share by Country (2020-2031)
Figure 47. Latin America Cancer Spit Test Device Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Cancer Spit Test Device Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Cancer Spit Test Device Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Cancer Spit Test Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Cancer Spit Test Device by Type (2020-2031)
Figure 57. Global Revenue Market Share of Cancer Spit Test Device by Type (2020-2031)
Figure 58. Global Cancer Spit Test Device Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Cancer Spit Test Device by Application (2020-2031)
Figure 60. Global Revenue Market Share of Cancer Spit Test Device by Application (2020-2031)
Figure 61. Global Cancer Spit Test Device Price (US$/Unit) by Application (2020-2031)
Figure 62. Cancer Spit Test Device Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
